Other factors in the tumor microenvironment that will lead to drug resistance include the presence of overexpressed growth factors such as vascular endothelial growth factor and cytokines including interleukin-6 (IL6) and nuclear factor-κB (NF-κB) [39]. The gene discussed is IL6; the disease is neoplasm.